Navigation Links
Some patients may not need insulin for long-term control of type 2 diabetes
Date:6/15/2008

Some patients with type 2 diabetes can control their disease for years yet avoid insulin injections by using multiple classes of oral diabetic medications, a new study found. The results were presented Sunday, June 15, at The Endocrine Society's 90th Annual Meeting in San Francisco.

Findings from the study contradict common beliefs about non-insulin diabetic medications, said principal investigator Arthur Swislocki, MD, of the Veterans Affairs (VA) Northern California Health Care System in Martinez. Oral diabetes medications help control blood glucose, or sugar, levels in people whose bodies still produce some insulin, as is true for many patients with type 2 diabetes.

"Generally, both patients and physicians believe that long-term use of oral diabetic medications is not possible because these drugs lose their effectiveness over time as the patient's pancreas fails," Swislocki said. "Our data suggest that some patients can remain in good glucose control for years using non-insulin, oral diabetic agents."

The study result is good news for people who need medical therapy for type 2 diabetes, according to Swislocki. "They may be able to delay or avoid the use of insulin," he said.

Some patients prefer pills over insulin injections because they are easier to use or because the patient fears needles or getting low blood sugar, as is possible with insulin treatment, he said.

Swislocki and his coworkers studied the VA medical records of 191 veterans (188 men and 3 women) with type 2 diabetes who received treatment beginning in 1992 and received follow-up for 15 consecutive years. Of these patients, 96 began treatment solely with oral drugs. The researchers found that 55 percent of the patients (53 of 96) who started treatment with oral diabetic agents were able to continue using them 15 years later and achieve good blood sugar control. A measure of long-term blood sugar controlhemoglobin A1cimproved from an average of nea
'/>"/>

Contact: Aaron Lohr
alohr@endo-society.org
240-482-1380
The Endocrine Society
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Nurses, Doctors, Patients to Protest Health Insurers at National Day of Action - June 19th
2. Joint distraction promotes structural repair in patients with severe knee osteoarthritis
3. 30 percent RA patients refractory to anti-TNFs achieve disease remission with tocilizumab plus metho
4. Abatacept and infliximab improve clinical response over time in methotrexate-refractory RA patients
5. Serum sodium predicts mortality 10 times higher in PAH patients
6. Syntermed licenses Emory imaging technology for improved evaluation of heart failure patients
7. Abbott Opens New State-of-the-Art R&D Facility to Help Bring Medicines to Patients Faster
8. Research shows patients must re-learn going from sitting to standing after total knee replacement
9. New self-management program offers significant benefits for arthritis patients with chronic pain
10. Adalimumab therapy effective in AS, RA and PsA patients refractory to other anti-TNF therapies
11. Biogen Idecs baminercept alfa shows promise in patients with rheumatoid arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...ICAGO, Dec. 3 Research ...evice and functional MRI (fMRI) have found that,c...ding to a study presented,today at the annual mee...,(RSNA). This is the first study using fMRI to map...n. , "We have shown that the brain has the ...
(Date:12/2/2008)...UISVILLE, Ky., Dec. 2 A...d meaningful images from the bits of information w... Grawemeyer Award for Psychology. , Anne Treism...y Professor,of psychology at Princeton Universit...ogy prize from among 28 nominations. , Trei...
(Date:12/2/2008)...A team of researchers from Monash University, The ...ical School and Vanda Pharmaceuticals has found a ...nd sleep disorders caused by shift work. , Dr S...of Psychology, Psychiatry and Psychological Medici...n receptors in the brain, could be a highly effect...
(Date:12/2/2008)...tients given Trasylol have a higher death risk, da...lthDay News) -- A new study casts more doubt on t...o limit bleeding in patients undergoing surgery. ,... in the United States, where it was removed from t... and Australian researchers reviewed findings from...
Breaking Medicine News(10 mins):Health News:Robotic Technology Improves Stroke Rehabilitation 2Health News:Robotic Technology Improves Stroke Rehabilitation 3Health News:Theory of How Brain Builds Images Earns Grawemeyer Prize 2Health News:New medication brings hope of jet lag cure 2Health News:Another Study Warns of Risk From Cardiac Surgery Drug 2
... have said in the British Medical Journal that the...tals since 1990, based on mythical safety risks, a...phones were banned in hospitals after fears of the...and to prevent the potential confusion between the...
...ar 500,000 Americans develop pneumococcal pneumoni... serious, possibly fatal, illness. The October iss...g the word: A vaccine is available that helps prot...pneumonia and reduces the serious complications of...
... with allergic symptoms like wheezing, asthma, ha...nsitization to their infants too, according to a s...ts that the current practice of avoiding skin test... 4 or 5 should be reconsidered, so children in thi...
... a clear indication in a scientific journal regard...ing clinical trial//, the drug was tested on human...re drug reaction. But for the timely emergency car...ve been history. A Dutch report documenting the ...
Other Medicine News:Health News:Allergy Sufferers Pass on Allergies to their Children 2
(Date:12/1/2008)...wire-USNewswire/ -- A study has found that positro...imaging the breast, is not affected by either brea...rs that limit the effectiveness of standard mammog... presented today at the annual meeting of the Radi..., "The ability of PEM to detect cancer does not ...
(Date:12/1/2008)...ith ENB-0040 at Children,s Hospital, Health Scienc... Enobia Pharma, an emerging Canadia...apeutics for serious bone disorders, today announc...rogram for hypophosphatasia was dosed. Enobia is i... ENB-0040 for the treatment of this rare and often...
(Date:12/1/2008)... December 9 at 11:00 am ET to Discuss Phase 2 Stud...O, Calif., Dec. 1 Sune...pharmaceutical company focused on the development ..., today announced new data from its studies of vor...sented during the 50th American Society of Hematol...
(Date:11/28/2008)...swire/ -- German biotech company,Partec is expand...oring and,AIDS patient follow-up diagnostics for ...08, 2.5 million patient tests have been performed ...CyFlow" system, supporting already,more than 1 mi...tion of the,Partec innovation, the average cost o...
Breaking Medicine Technology:New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2Medifast Adds New Crunchy Bars to Product Line 28861 1Medifast Adds New Crunchy Bars to Product Line 28861 2NCPA Statement on November 4th Election Results 28860 1NCPA Statement on November 4th Election Results 28860 2ConjuChem Provides Development Update 8911 1ConjuChem Provides Development Update 8911 2ConjuChem Provides Development Update 8911 3State fund advances titanium powder research 9 other Iowa State projects 5736 1State fund advances titanium powder research 9 other Iowa State projects 5736 2State fund advances titanium powder research 9 other Iowa State projects 5736 3State fund advances titanium powder research 9 other Iowa State projects 5736 4
BD Vacutainer® PST™ Tubes contain spray-coated lithium heparin and a gel for plasma separation. They are used for plasma determinations in chemistry.
MONOJECT Red/Yellow Mottled Stopper
BD Vacutainer® Specialty Tubes - Thrombin
BD Vacutainer® PST™ Tubes contain spray-coated lithium heparin and a gel for plasma separation. They are used for plasma determinations in chemistry.
Medicine Products: